Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Garbe

Showing results (331-340 of 501) with videos related to

Pageof 51
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology GroupRoland Kaufmann, Konstanze Spieth, Ulrike Leiter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2017
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant MelanomaHeike Niessner, Tobias Sinnberg, Corinna Kosnopfel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Melanoma Research|November 10, 2007
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanomaClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Plos Medicine|February 22, 2014
Quantitative measurement of melanoma spread in sentinel lymph nodes and survivalAnja Ulmer, Klaus Dietz, Isabelle Hodak, et al.
Melanoma Research|March 14, 2008
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative settingClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Nature Communications|October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibitionChristopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.
Journal of the National Cancer Institute|September 20, 2017
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant TherapyStefan Suciu, Alexander M M Eggermont, Paul Lorigan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2011
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practiceClaus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
La Radiologia Medica|May 23, 2022
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic reviewValentina Lancellotta, Laura Del Regno, Alessandro Di Stefani, et al.
Pageof 51

Showing results (331-340 of 501) with videos related to

Sort By:
Pageof 51
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology GroupRoland Kaufmann, Konstanze Spieth, Ulrike Leiter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2017
BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant MelanomaHeike Niessner, Tobias Sinnberg, Corinna Kosnopfel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 31, 2017
Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Melanoma Research|November 10, 2007
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanomaClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Plos Medicine|February 22, 2014
Quantitative measurement of melanoma spread in sentinel lymph nodes and survivalAnja Ulmer, Klaus Dietz, Isabelle Hodak, et al.
Melanoma Research|March 14, 2008
Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative settingClaus Garbe, Axel Hauschild, Matthias Volkenandt, et al.
Nature Communications|October 9, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibitionChristopher Schroeder, Sergios Gatidis, Olga Kelemen, et al.
Journal of the National Cancer Institute|September 20, 2017
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant TherapyStefan Suciu, Alexander M M Eggermont, Paul Lorigan, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2011
Histopathological diagnostics of malignant melanoma in accordance with the recent AJCC classification 2009: Review of the literature and recommendations for general practiceClaus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
La Radiologia Medica|May 23, 2022
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic reviewValentina Lancellotta, Laura Del Regno, Alessandro Di Stefani, et al.
Pageof 51